Psoriasis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have skin damage that is known or suspected to be caused by your immune system attacking your own body (autoimmune, immune-related, or inflammatory condition)
- You have a blistering skin disease caused by the immune system, such as pemphigus or pemphigoid
- You have a systemic autoimmune disease (a condition affecting multiple parts of the body) that also affects the skin, such as lupus, scleroderma, or dermatomyositis
- You have a form of lupus that mainly affects the skin
- You have an immune-related skin condition such as psoriasis or eczema
- Your skin condition was caused or triggered by a medication or medical treatment
- You are currently receiving, or may soon receive, a newer or innovative treatment such as gene therapy, cell therapy, or certain cancer immunotherapy drugs (confirm with trial site)
- You are an adult or a child aged 6 or older
- Your skin condition is suspected (but not yet confirmed) to be related to an immune system problem
Who may not be able to join:
- Children under 6 years old
- People who are pregnant or currently breastfeeding
- People who are under legal protective supervision, such as those with a court-appointed guardian or curator
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Chloé BOST, MD, PhD, University Hospital, Toulouse
Phone: 5 61 77 61 44
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Building a collection of biological samples and clinical-biological data from patients with autoimmune, dysimmune or auto-inflammatory dermatological disease
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.